Home Cart 0 Sign in  

[ CAS No. 31949-21-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 31949-21-0
Chemical Structure| 31949-21-0
Structure of 31949-21-0 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 31949-21-0 ]

Related Doc. of [ 31949-21-0 ]

Alternatived Products of [ 31949-21-0 ]
Product Citations

Product Citations

Fabian Fischer ; Julian Schliehe-Diecks ; Jia-Wey Tu , et al. DOI: PubMed ID:

Abstract: Histone deacetylase inhibitors (HDACi) are established anticancer drugs, especially in hematological cancers. This study aimed to design, synthesize, and evaluate a set of HDACi featuring a pentyloxyamide connecting unit linker region and substituted phenylthiazole cap groups. A structural optimization program yielded HDACi with nanomolar inhibitory activity against histone deacetylase class I/IIb enzymes. The novel inhibitors (4d and 4m) showed superior antileukemic activity compared to several approved HDACi. Furthermore, 4d and 4m displayed synergistic activity when combined with chemotherapeutics, decitabine, and clofarabine. In vitro pharmacokinetic studies showed the most promising profile for 4d with intermediate microsomal stability, excellent plasma stability, and concentration-independent plasma protein binding. Additionally, 4d demonstrated comparable in vivo pharmacokinetics to vorinostat. When administered in vivo, 4d effectively inhibited the proliferation of leukemia cells without causing toxicity. Furthermore, the binding modes of 4d and 4m to the catalytic domain 2 of HDAC6 from Danio rerio were determined by X-ray crystallography.

Purchased from AmBeed: ; ; ;

Product Details of [ 31949-21-0 ]

CAS No. :31949-21-0 MDL No. :MFCD00000196
Formula : C9H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :GKNCPTLOPRDYMH-UHFFFAOYSA-N
M.W : 229.07 Pubchem ID :123440
Synonyms :
2-Bromo-1-(2-methoxyphenyl)ethanone
Chemical Name :2-Bromo-1-(2-methoxyphenyl)ethanone

Calculated chemistry of [ 31949-21-0 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.0
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.83
Log Po/w (XLOGP3) : 2.61
Log Po/w (WLOGP) : 2.27
Log Po/w (MLOGP) : 1.89
Log Po/w (SILICOS-IT) : 2.71
Consensus Log Po/w : 2.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.08
Solubility : 0.192 mg/ml ; 0.000838 mol/l
Class : Soluble
Log S (Ali) : -2.81
Solubility : 0.353 mg/ml ; 0.00154 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0419 mg/ml ; 0.000183 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.68

Safety of [ 31949-21-0 ]

Signal Word:Danger Class:8
Precautionary Statements:P301+P330+P331-P303+P361+P353-P363-P304+P340-P310-P321-P260-P264-P280-P305+P351+P338-P405-P501 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 31949-21-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31949-21-0 ]
  • Downstream synthetic route of [ 31949-21-0 ]

[ 31949-21-0 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 31949-21-0 ]
  • [ 34589-97-4 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With hexamethylenetetramine In diethyl ether at 20℃; for 12 h;
Stage #2: With hydrogenchloride; water In ethanol for 3 h; Reflux
General procedure: To a stirred solution of 2-methoxyphenacyl bromide (7a)/phenacyl bromide (7b) (1 mmol, 1 equiv) in diethyl ether (13 mL) was added hexamethylenetetramine (1 mmol, 1 equiv) all at once and the mixture was stirred for 12 h at room temperature (solid formation observed). The resulting solid was filtered, washed with diethyl ether (15 mL), and dried under reduced pressure to afford the quaternary salt, which was next placed in a two-necked round-bottomed flask fitted with reflux condenser and EtOH (22 mL) was added to it. Concentrated HCl (0.6 mL) was added to it and the mixture was refluxed for 3 h (solid formed). After cooling to room temperature, the solid was filtered, washed with EtOH (20 mL), and dried under vacuum to afford pure 2- methoxybenzoylmethylammonium chloride (8a)/benzoylmethylammonium chloride (8b) salt. 2-Amino-1-(2-methoxyphenyl)ethanone hydrochloride (8a): Yield: 88percent; brown solid; mp 102–104C; 1 H NMR (300 MHz, CDCl3): δ 7.26 (1H, d, J = 8.7 Hz), 7.11 (1H, t, J = 7.2 Hz), 4.33 (2H, q, J = 5.4 Hz), 3.94 (3H, s); 13C NMR (75 MHz, CDCl3): δ 192.1, 159.6, 135.9, 130.0, 120.7, 112.9, 56.1, 48.7.
88%
Stage #1: With hexamethylenetetramine In diethyl ether at 20℃; for 12 h;
Stage #2: With hydrogenchloride In ethanol; water for 3 h; Reflux
General procedure: Hexamethylenetetramine (1 mmol, 1 equivalent) was added to a stirred solution of 2-methoxyphenacyl bromide (compound 7a) / phenacyl bromide (compound 7b) (1 mmol, 1 equiv.) In diethyl ether And the mixture was stirred at room temperature for 12 hours (solid formation). The resulting solid was filtered, washed with diethyl ether (15 mL) and dried under reduced pressure to obtain quaternary salt, which was then placed in a 2-neck round bottom flask equipped with a reflux condenser and EtOH (22 mL) was added. After cooling to room temperature, the solid was filtered off, washed with EtOH (20 mL) and dried under vacuum to give the pure 2-methoxybenzoylmethylammonium chloride (compound 8a) / benzoylmethylammonium chloride (compound 8b) salt.
88%
Stage #1: With hexamethylenetetramine In diethyl ether at 20℃; for 12 h;
Stage #2: With hydrogenchloride In ethanol; water for 3 h; Reflux
General procedure: To the mixture was added diethyl ether (13 mL)2-methoxyphenacyl bromide (compound 7a) / phenacyl bromide (compound 7b)Was added hexamethylenetetramine (1 mmol, 1 equiv) to a solution (1 mmol, 1 equiv.),Was added in one portion, and the mixture was stirred at room temperature for 12 hours (solid formation).The resulting solid was filtered, washed with diethyl ether (15 mL) and dried under reduced pressure to give a quaternary salt,Was placed in a two-neck round bottom flask equipped with a reflux condenser and EtOH (22 mL) was added.Cool to room temperature,The solid was filtered, washed with EtOH (20 mL) and dried under vacuum to give the pure 2-methoxybenzoylmethylammonium chloride (Compound 8a) / benzoylmethylammonium chloride (Compound 8b) salt.
Reference: [1] Bulletin of the Korean Chemical Society, 2017, vol. 38, # 12, p. 1481 - 1485
[2] Patent: KR101916106, 2018, B1, . Location in patent: Paragraph 0060; 0070-0073
[3] Patent: KR101926612, 2018, B1, . Location in patent: Paragraph 0023; 0033; 0034; 0036
[4] Patent: WO2008/145398, 2008, A1,
Recommend Products
Same Skeleton Products

Technical Information

• Alkyl Halide Occurrence • Baeyer-Villiger Oxidation • Barbier Coupling Reaction • Baylis-Hillman Reaction • Benzylic Oxidation • Birch Reduction • Blanc Chloromethylation • Bucherer-Bergs Reaction • Clemmensen Reduction • Corey-Bakshi-Shibata (CBS) Reduction • Corey-Chaykovsky Reaction • Fischer Indole Synthesis • Friedel-Crafts Reaction • General Reactivity • Grignard Reaction • Henry Nitroaldol Reaction • Hiyama Cross-Coupling Reaction • Horner-Wadsworth-Emmons Reaction • Hydride Reductions • Hydrogenolysis of Benzyl Ether • Kinetics of Alkyl Halides • Kumada Cross-Coupling Reaction • Lawesson's Reagent • Leuckart-Wallach Reaction • McMurry Coupling • Meerwein-Ponndorf-Verley Reduction • Nomenclature of Ethers • Passerini Reaction • Paternò-Büchi Reaction • Petasis Reaction • Peterson Olefination • Pictet-Spengler Tetrahydroisoquinoline Synthesis • Preparation of Aldehydes and Ketones • Preparation of Alkylbenzene • Preparation of Amines • Preparation of Ethers • Prins Reaction • Reactions of Aldehydes and Ketones • Reactions of Alkyl Halides with Reducing Metals • Reactions of Amines • Reactions of Benzene and Substituted Benzenes • Reactions of Dihalides • Reactions of Ethers • Reformatsky Reaction • Robinson Annulation • Schlosser Modification of the Wittig Reaction • Schmidt Reaction • Specialized Acylation Reagents-Ketenes • Stille Coupling • Stobbe Condensation • Substitution and Elimination Reactions of Alkyl Halides • Suzuki Coupling • Tebbe Olefination • Ugi Reaction • Vilsmeier-Haack Reaction • Wittig Reaction • Wolff-Kishner Reduction
Historical Records

Related Functional Groups of
[ 31949-21-0 ]

Aryls

Chemical Structure| 2491-36-3

[ 2491-36-3 ]

2-Bromo-1-(2-hydroxyphenyl)ethanone

Similarity: 0.92

Chemical Structure| 115787-50-3

[ 115787-50-3 ]

5-(2-Bromoacetyl)-2-hydroxybenzaldehyde

Similarity: 0.91

Chemical Structure| 5000-65-7

[ 5000-65-7 ]

2-Bromo-1-(3-methoxyphenyl)ethanone

Similarity: 0.91

Chemical Structure| 1835-02-5

[ 1835-02-5 ]

2-Bromo-1-(3,4-dimethoxyphenyl)ethanone

Similarity: 0.86

Chemical Structure| 2491-38-5

[ 2491-38-5 ]

2-Bromo-1-(4-hydroxyphenyl)ethanone

Similarity: 0.85

Bromides

Chemical Structure| 2491-36-3

[ 2491-36-3 ]

2-Bromo-1-(2-hydroxyphenyl)ethanone

Similarity: 0.92

Chemical Structure| 115787-50-3

[ 115787-50-3 ]

5-(2-Bromoacetyl)-2-hydroxybenzaldehyde

Similarity: 0.91

Chemical Structure| 5000-65-7

[ 5000-65-7 ]

2-Bromo-1-(3-methoxyphenyl)ethanone

Similarity: 0.91

Chemical Structure| 1835-02-5

[ 1835-02-5 ]

2-Bromo-1-(3,4-dimethoxyphenyl)ethanone

Similarity: 0.86

Chemical Structure| 2491-38-5

[ 2491-38-5 ]

2-Bromo-1-(4-hydroxyphenyl)ethanone

Similarity: 0.85

Ethers

Chemical Structure| 5000-65-7

[ 5000-65-7 ]

2-Bromo-1-(3-methoxyphenyl)ethanone

Similarity: 0.91

Chemical Structure| 1835-02-5

[ 1835-02-5 ]

2-Bromo-1-(3,4-dimethoxyphenyl)ethanone

Similarity: 0.86

Chemical Structure| 20628-07-3

[ 20628-07-3 ]

1-(2-Methoxy-5-methylphenyl)ethanone

Similarity: 0.85

Chemical Structure| 6161-64-4

[ 6161-64-4 ]

1-(2-Methoxy-6-methylphenyl)ethanone

Similarity: 0.85

Chemical Structure| 111841-05-5

[ 111841-05-5 ]

2-Bromo-1-(5-chloro-2-methoxyphenyl)ethanone

Similarity: 0.83

Ketones

Chemical Structure| 2491-36-3

[ 2491-36-3 ]

2-Bromo-1-(2-hydroxyphenyl)ethanone

Similarity: 0.92

Chemical Structure| 115787-50-3

[ 115787-50-3 ]

5-(2-Bromoacetyl)-2-hydroxybenzaldehyde

Similarity: 0.91

Chemical Structure| 5000-65-7

[ 5000-65-7 ]

2-Bromo-1-(3-methoxyphenyl)ethanone

Similarity: 0.91

Chemical Structure| 1835-02-5

[ 1835-02-5 ]

2-Bromo-1-(3,4-dimethoxyphenyl)ethanone

Similarity: 0.86

Chemical Structure| 2491-38-5

[ 2491-38-5 ]

2-Bromo-1-(4-hydroxyphenyl)ethanone

Similarity: 0.85

; ;